MSB 2.51% 97.0¢ mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-60

  1. 12,446 Posts.
    lightbulb Created with Sketch. 3374
    This is great news & will unlock other roadblocks that Mesoblast has been having

    We are not quite there as yet, but well done to Mesoblast and all involved.

    The road to redemption, recovery and respect starts today.

    GL MSB’ers - onwards & upwards
    <insert happy dance GIF>
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.